Molecular evaluation of Hepatocyte Growth Factor (HGF) as a potential Biomarker to detect Hepatocellular Carcinoma
Abdallah, A., Sakr, M., Sharawy, A., Ismail, H. (2017). Molecular evaluation of Hepatocyte Growth Factor (HGF) as a potential Biomarker to detect Hepatocellular Carcinoma. EKB Journal Management System, 3(1), 1-10. doi: 10.21608/rjab.2017.57585
Amira Abdallah; Moustafa A. Sakr; Ahmed Sharawy; Hisham A. Ismail. "Molecular evaluation of Hepatocyte Growth Factor (HGF) as a potential Biomarker to detect Hepatocellular Carcinoma". EKB Journal Management System, 3, 1, 2017, 1-10. doi: 10.21608/rjab.2017.57585
Abdallah, A., Sakr, M., Sharawy, A., Ismail, H. (2017). 'Molecular evaluation of Hepatocyte Growth Factor (HGF) as a potential Biomarker to detect Hepatocellular Carcinoma', EKB Journal Management System, 3(1), pp. 1-10. doi: 10.21608/rjab.2017.57585
Abdallah, A., Sakr, M., Sharawy, A., Ismail, H. Molecular evaluation of Hepatocyte Growth Factor (HGF) as a potential Biomarker to detect Hepatocellular Carcinoma. EKB Journal Management System, 2017; 3(1): 1-10. doi: 10.21608/rjab.2017.57585

Molecular evaluation of Hepatocyte Growth Factor (HGF) as a potential Biomarker to detect Hepatocellular Carcinoma

Research Journal of Applied Biotechnology
Article 8, Volume 3, Issue 1, June 2017, Page 1-10  XML PDF (546.48 K)
Document Type: Original Article
DOI: 10.21608/rjab.2017.57585
View on SCiNiTO View on SCiNiTO
Authors
Amira Abdallah email 1; Moustafa A. Sakrorcid 1; Ahmed Sharawy2; Hisham A. Ismail1
1Molecular diagnostics and therapeutics department, Genetic Engineering and Biotechnology Research Institute (GEBRI), University of Sadat City, Sadat city, Egypt
2Clinical Pathology Department, National Liver Institute, Menofia University, Menofia, Egypt
Abstract
This study was carried out to investigate the noninvasive expression level of hepatocyte growth factor (HGF) in hepatocellular carcinoma patients and its relationship with diagnostic parameters.To active this goal we used thirty six patient divide to fourteen with HCC, twelve patients with HCV and ten healthy control patient matched in age and sex were investigated. HGF level wasdetected by quantitative polymerase chain reaction (qRT-PCR). The median age of the patients was 51 years (rang 44-58 years); where males constituted the majority of the group (69.4%). The entire patient had cirrhotic history. None of the patients were pretreated with local therapies. The baseline noninvasive HGF level wassignificantly higher in patient HCC than in the HCV and control groups (p=0.028), whereas HGF level was alsohigher in HCV patient than healthy patient. Further the correlation between the level of HGF and all laboratory parameters was tested. We found that there is a good positive relationship between HGF levels and SGPT (ALT), SOGT (AST), Platelets count.Finally we compared the predicative accuracy of HGF and a conventional tumor marker AFP by ROC curve; we found that the sensitivity of HGF (85.7%) to predict the HCC is higher than AFP (73%), and also the specificity.Overall, these results suggest that HGF could serve as a useful tumor biomarker for prediction of HCC in comparing with, HCV, and healthy control results.

Keywords
HCC; HGF; AFP; ROC curve; Egyptian patients
Statistics
Article View: 112
PDF Download: 311